APA

Palmieri G., Morabito A., Rea A., Lauria R., Montesarchio V., Biondi E., Caraglia M., Tagliaferri P. & Bianco A. (20121002). Maintenance therapy with recombinant interferon alpha-2B (alpha IFN) in prognostically unfavourable aggressive non-Hodgkin's lymphomas (NHL). : Oncology reports.

Chicago

Palmieri G, Morabito A, Rea A, Lauria R, Montesarchio V, Biondi E, Caraglia M, Tagliaferri P and Bianco A. 20121002. Maintenance therapy with recombinant interferon alpha-2B (alpha IFN) in prognostically unfavourable aggressive non-Hodgkin's lymphomas (NHL). : Oncology reports.

Harvard

Palmieri G., Morabito A., Rea A., Lauria R., Montesarchio V., Biondi E., Caraglia M., Tagliaferri P. and Bianco A. (20121002). Maintenance therapy with recombinant interferon alpha-2B (alpha IFN) in prognostically unfavourable aggressive non-Hodgkin's lymphomas (NHL). : Oncology reports.

MLA

Palmieri G, Morabito A, Rea A, Lauria R, Montesarchio V, Biondi E, Caraglia M, Tagliaferri P and Bianco A. Maintenance therapy with recombinant interferon alpha-2B (alpha IFN) in prognostically unfavourable aggressive non-Hodgkin's lymphomas (NHL). : Oncology reports. 20121002.